At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...

Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has ...

Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

The companies will invest up to $1 billion over five years to support discovery and development powered by artificial ...

With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

AI and genetics are creating a 'seismic shift' in the pharmaceutical business, experts on Asian Financial Forum panel say ...

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Chai Discovery, Noetik, and Boltz have entered multi-year pharma partnerships focused on models, not molecules, hinting at AI’s “infrastructure moment.” ...

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...

UCL joins global €60m AI-driven drug discovery initiative to generate open datasets and accelerate new medicines using AI models ...